| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2008 | WO2008157833A1 Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
| 12/24/2008 | WO2008157802A1 3-hydroxyisothiazole-4-carboxamidine derivatives as chk2 inhibitors |
| 12/24/2008 | WO2008157791A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones |
| 12/24/2008 | WO2008157787A2 Hydroxylated tolans and related compounds in the treatment of cancer |
| 12/24/2008 | WO2008157786A1 Substituted n-aryl pyridinones as fibrotic inhibitors |
| 12/24/2008 | WO2008157775A1 Composition and method for treating rheumatoid arthritis |
| 12/24/2008 | WO2008157771A1 Composition and method for treating connective tissue damage by transmucosal administration |
| 12/24/2008 | WO2008157767A1 Composition and method for treating connective tissue damage |
| 12/24/2008 | WO2008157753A1 Methods of treatment for spinal muscular atrophy |
| 12/24/2008 | WO2008157752A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 12/24/2008 | WO2008157751A2 Substituted imidazoheterocycles |
| 12/24/2008 | WO2008157741A1 Spiroindolines as modulators of chemokine receptors |
| 12/24/2008 | WO2008157740A2 Faah inhibitors |
| 12/24/2008 | WO2008157726A1 Boron-containing small molecules |
| 12/24/2008 | WO2008157711A2 Materials comprising water-soluble polymer particles and methods of making and using them |
| 12/24/2008 | WO2008157658A1 Deuterium-enriched montelukast |
| 12/24/2008 | WO2008157657A1 Deuterium-enriched tenofovir |
| 12/24/2008 | WO2008157656A1 Deuterium-enriched salmeterol |
| 12/24/2008 | WO2008157652A1 Deuterium-enriched fluticasone propionate |
| 12/24/2008 | WO2008157635A2 Synthetic bile acid composition, method, and preparation |
| 12/24/2008 | WO2008157627A1 Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
| 12/24/2008 | WO2008157614A2 Sustained intraocular delivery of drugs from biodegradable polymeric microparticles |
| 12/24/2008 | WO2008157608A1 Composite scaffolds for tissue regeneration |
| 12/24/2008 | WO2008157575A1 Protein kinase inhibitors and methods for using thereof |
| 12/24/2008 | WO2008157570A2 Device and method for restoration of the condition of blood |
| 12/24/2008 | WO2008157565A1 Deuterium-enriched ezetimibe |
| 12/24/2008 | WO2008157563A2 Deuterium-enriched clopidogrel |
| 12/24/2008 | WO2008157562A2 Deuterium-enriched olanzapine |
| 12/24/2008 | WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders |
| 12/24/2008 | WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease |
| 12/24/2008 | WO2008157460A1 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 12/24/2008 | WO2008157408A2 Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity |
| 12/24/2008 | WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 12/24/2008 | WO2008157404A2 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators |
| 12/24/2008 | WO2008157365A2 Vinylazacycloalkanes for treating neuropathic pain |
| 12/24/2008 | WO2008157361A1 α-CHLORO AND α-BROMO PHOSPHONATE ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF |
| 12/24/2008 | WO2008157330A1 Chemical compounds |
| 12/24/2008 | WO2008157323A1 Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film |
| 12/24/2008 | WO2008157308A2 A zwitterion solution for low-volume therapeutic delivery |
| 12/24/2008 | WO2008157302A2 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 12/24/2008 | WO2008157288A2 A baclofen solution for low-volume therapeutic delivery |
| 12/24/2008 | WO2008157273A1 Chemical compounds |
| 12/24/2008 | WO2008157272A2 Deuterium-enriched tamsulosin |
| 12/24/2008 | WO2008157271A1 Deuterium-enriched escitalopram |
| 12/24/2008 | WO2008157240A1 Substituted piperazines |
| 12/24/2008 | WO2008157235A1 Rsk inhibitors as anti-septicemia agents |
| 12/24/2008 | WO2008157230A1 Rsk inhibitors as anti-angiogenic therapeutics |
| 12/24/2008 | WO2008157216A1 Process for the manufacture of benzylsulfonylarenes |
| 12/24/2008 | WO2008157211A1 Crystalline forms of (3aalpha,4beta,5alpha,7beta,7aalpha)-4-(octahydro-5-ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,-7-ep0xy-2h-isoind0l-2-yl)- |
| 12/24/2008 | WO2008157210A1 Compounds and compositions as itpkb inhibitors |
| 12/24/2008 | WO2008157205A2 Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp |
| 12/24/2008 | WO2008157191A2 Quinazoline derivatives as pi3 kinase inhibitors |
| 12/24/2008 | WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors |
| 12/24/2008 | WO2008157103A2 Modified release solid or semi-solid dosage forms |
| 12/24/2008 | WO2008157094A1 Improving the tolerability of mirtazapine and a second active by using them in combination |
| 12/24/2008 | WO2008157003A2 Chemical inhibitors of bfl-1 and related methods |
| 12/24/2008 | WO2008156869A2 Sirtuin modulating thiazolopyridine compounds |
| 12/24/2008 | WO2008156868A2 Compositions and methods of treating chronic kidney disease |
| 12/24/2008 | WO2008156866A1 Sirtuin modulating imidazothiazole compounds |
| 12/24/2008 | WO2008156833A2 G2a receptor as a therapeutic target |
| 12/24/2008 | WO2008156831A2 Renin inhibitors |
| 12/24/2008 | WO2008156820A1 Short acting phenylalkylamine calcium channel blockers and uses thereof |
| 12/24/2008 | WO2008156817A2 Renin inhibitors |
| 12/24/2008 | WO2008156816A2 Renin inhibitors |
| 12/24/2008 | WO2008156783A2 Family of pfkfb3 inhibitors with anti-neoplastic activities |
| 12/24/2008 | WO2008156781A1 Amine salts of a crth2 antagonist |
| 12/24/2008 | WO2008156780A1 Particulates of a crth2 antagonist |
| 12/24/2008 | WO2008156758A1 Bifunctional synthetic molecules |
| 12/24/2008 | WO2008156757A1 Indazole compounds for activating glucokinase |
| 12/24/2008 | WO2008156749A1 Combination therapy for depression |
| 12/24/2008 | WO2008156739A1 Heterocyclic compounds and use thereof as erk inhibitors |
| 12/24/2008 | WO2008156726A1 Inhibitors of janus kinases |
| 12/24/2008 | WO2008156719A1 Steroid-sparing methods of treating brain edema |
| 12/24/2008 | WO2008156707A1 Therapeutic compounds |
| 12/24/2008 | WO2008156671A2 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| 12/24/2008 | WO2008156654A2 Cytoskeleton modulators for treating metabolic disorders |
| 12/24/2008 | WO2008156646A1 Topical composition for treating pain |
| 12/24/2008 | WO2008156645A2 Pharmaceutical compositions and uses |
| 12/24/2008 | WO2008156644A2 Stat modulators |
| 12/24/2008 | WO2008156636A1 Antimicrobial coatings for conversion of spores into their bacterial vegetative form for decontamination |
| 12/24/2008 | WO2008156632A1 Azapeptide derivatives |
| 12/24/2008 | WO2008156629A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 12/24/2008 | WO2008156614A2 Imidazopyrazines as protein kinase inhibitors |
| 12/24/2008 | WO2008156610A2 Antibiotic compounds |
| 12/24/2008 | WO2008156607A1 Substituted pyrimidinones |
| 12/24/2008 | WO2008156601A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases |
| 12/24/2008 | WO2008156580A1 Triazole derivatives for treating alzheimer's disease and related conditions |
| 12/24/2008 | WO2008156573A1 Kinase inhibitors, compositions thereof, and methods of use therewith |
| 12/24/2008 | WO2008156550A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
| 12/24/2008 | WO2008156527A2 Cross-media voice mail notification and delivery |
| 12/24/2008 | WO2008156513A2 Methods to protect skeletal muscle against injury |
| 12/24/2008 | WO2008156494A1 Use of high-dose oxazaphosphorine drugs in combination with monoclonal antibodies for treating immune disorders |
| 12/24/2008 | WO2008156365A1 Treatment of meconium aspiration syndrome with estrogens |
| 12/24/2008 | WO2008156360A1 Modulation of intestinal flora of hiv patients |
| 12/24/2008 | WO2008156354A1 Modulation of intestinal flora of hiv patients |
| 12/24/2008 | WO2008156331A2 Novel use of lignan compounds |
| 12/24/2008 | WO2008156217A2 Pharmaceutical solid preparation comprising benzazepines and production method thereof |
| 12/24/2008 | WO2008156208A1 5-phenyl-3-pyridazinone derivative |
| 12/24/2008 | WO2008156174A1 Pyrazinamide compound |
| 12/24/2008 | WO2008156172A1 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of uterine cancer, breast cancer and bladder cancer |